CA2655563A1 - Procedes de detection de complexes moleculaires - Google Patents

Procedes de detection de complexes moleculaires Download PDF

Info

Publication number
CA2655563A1
CA2655563A1 CA002655563A CA2655563A CA2655563A1 CA 2655563 A1 CA2655563 A1 CA 2655563A1 CA 002655563 A CA002655563 A CA 002655563A CA 2655563 A CA2655563 A CA 2655563A CA 2655563 A1 CA2655563 A1 CA 2655563A1
Authority
CA
Canada
Prior art keywords
antibody
protein
biological sample
array
microarray slide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002655563A
Other languages
English (en)
Inventor
Brian B. Haab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Van Andel Research Institute
Original Assignee
Van Andel Research Institute
Brian B. Haab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Van Andel Research Institute, Brian B. Haab filed Critical Van Andel Research Institute
Publication of CA2655563A1 publication Critical patent/CA2655563A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
CA002655563A 2006-06-15 2007-06-15 Procedes de detection de complexes moleculaires Abandoned CA2655563A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81383806P 2006-06-15 2006-06-15
US60/813,838 2006-06-15
PCT/US2007/071382 WO2007147141A2 (fr) 2006-06-15 2007-06-15 Procédés de détection de complexes moléculaires

Publications (1)

Publication Number Publication Date
CA2655563A1 true CA2655563A1 (fr) 2007-12-21

Family

ID=38832921

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002655563A Abandoned CA2655563A1 (fr) 2006-06-15 2007-06-15 Procedes de detection de complexes moleculaires

Country Status (4)

Country Link
EP (1) EP2044437A4 (fr)
AU (1) AU2007260649A1 (fr)
CA (1) CA2655563A1 (fr)
WO (1) WO2007147141A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010148365A2 (fr) 2009-06-19 2010-12-23 The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona For And On Behalf Of Arizona State University Réseaux de composés pour profilage d'échantillon
US10758886B2 (en) 2015-09-14 2020-09-01 Arizona Board Of Regents On Behalf Of Arizona State University Conditioned surfaces for in situ molecular array synthesis
AU2017281039A1 (en) 2016-06-20 2019-01-24 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
AU2017281040A1 (en) 2016-06-20 2019-01-24 Healthtell Inc. Methods for diagnosis and treatment of autoimmune diseases
AU2017357818A1 (en) 2016-11-11 2019-05-30 HealthTell, Inc. Methods for identifying candidate biomarkers
US20200209241A1 (en) 2017-09-15 2020-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
EP4038222A4 (fr) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University Procédés et compositions pour identifier des néo-antigènes destinés à être utilisés dans le traitement et la prévention du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
CA2504481A1 (fr) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systemes d'interception et d'analyse de particules biologiques et procedes d'utilisation de ceux-ci
US20030153013A1 (en) * 2002-11-07 2003-08-14 Ruo-Pan Huang Antibody-based protein array system

Also Published As

Publication number Publication date
EP2044437A2 (fr) 2009-04-08
EP2044437A4 (fr) 2009-11-25
AU2007260649A1 (en) 2007-12-21
WO2007147141A3 (fr) 2008-02-07
WO2007147141A2 (fr) 2007-12-21

Similar Documents

Publication Publication Date Title
US6197599B1 (en) Method to detect proteins
US7674599B2 (en) Methods of using antibodies to detect alpha-synuclein in fluid samples
CN104374919B (zh) 糖蛋白的测定方法、试剂及糖链标记物
JP5897638B2 (ja) 微量ヒト血漿タンパク質バイオマーカーの新規なパネルを使用した肝線維症の臨床診断
US20080139406A1 (en) Allergen-Microarray Assay
CA2655563A1 (fr) Procedes de detection de complexes moleculaires
US9309312B2 (en) Immunoassay method for human CXCL1 protein
US20080161198A1 (en) Method and arrays for detecting biological molecules
JP4584828B2 (ja) 短いエピトープに対して向けられる複数組のディジタル抗体、およびその使用
JP2009020049A (ja) 脳血管疾患の診断方法
JP2001519894A (ja) リソソーム蓄積症の早期検出法
CA2662012C (fr) Isoformes et procedes de detection de boris et traitement de maladie
CN105548561B (zh) 阿尔茨海默病的诊断药和诊断方法
WO2012165926A2 (fr) Marqueur de diagnostic du cancer du foie contenant des anticorps anti-atic, et composition utilisée dans le diagnostic du cancer du foie et contenant son antigène
JP5280214B2 (ja) 炎症性腸疾患の診断方法
WO2009055880A2 (fr) Nouveau procédé de diagnostic du syndrome de sjögren
JP2010085375A (ja) 細胞増殖を伴う糖尿病合併症の検査のための方法、組成物およびキット
CN101120100A (zh) 通过包括转录因子测定的生物标志分析描绘肿瘤的方法和试剂盒
KR102131860B1 (ko) 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
US20050032117A1 (en) Method for assessment of cystic lung fibrosis
AU778672B2 (en) Assays
US20030049626A1 (en) Antibody-based analysis of matrix protein arrays
JP5750646B2 (ja) Ｓｃｃａ２濃度測定によるアレルギー疾患の検査方法
JP5750645B2 (ja) アレルギー疾患の検査方法
EP3191842A1 (fr) Procédés pour diagnostiquer et traiter la sclérose en plaques par la détection de composants de protéine altérés dans le sérum

Legal Events

Date Code Title Description
FZDE Discontinued